JP5170723B2 - 活性薬剤の制御放出用錠剤 - Google Patents

活性薬剤の制御放出用錠剤 Download PDF

Info

Publication number
JP5170723B2
JP5170723B2 JP53089798A JP53089798A JP5170723B2 JP 5170723 B2 JP5170723 B2 JP 5170723B2 JP 53089798 A JP53089798 A JP 53089798A JP 53089798 A JP53089798 A JP 53089798A JP 5170723 B2 JP5170723 B2 JP 5170723B2
Authority
JP
Japan
Prior art keywords
weight
barrier layer
tablet
active agent
aqueous medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP53089798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001508440A (ja
JP2001508440A5 (enExample
Inventor
チウ，イーホン
トライベデイ，ジエイ・エス
グラハム，シヤロン・エル
フラツド，コレツト・エム
クリル，ステイーブン・エル
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of JP2001508440A publication Critical patent/JP2001508440A/ja
Publication of JP2001508440A5 publication Critical patent/JP2001508440A5/ja
Application granted granted Critical
Publication of JP5170723B2 publication Critical patent/JP5170723B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP53089798A 1997-01-10 1997-12-18 活性薬剤の制御放出用錠剤 Expired - Fee Related JP5170723B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78176197A 1997-01-10 1997-01-10
US08/781,761 1997-01-10
PCT/US1997/023358 WO1998030208A1 (en) 1997-01-10 1997-12-18 Tablet for the controlled release of active agents

Publications (3)

Publication Number Publication Date
JP2001508440A JP2001508440A (ja) 2001-06-26
JP2001508440A5 JP2001508440A5 (enExample) 2005-06-16
JP5170723B2 true JP5170723B2 (ja) 2013-03-27

Family

ID=25123834

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53089798A Expired - Fee Related JP5170723B2 (ja) 1997-01-10 1997-12-18 活性薬剤の制御放出用錠剤

Country Status (8)

Country Link
US (1) US6033685A (enExample)
EP (1) EP0951279A1 (enExample)
JP (1) JP5170723B2 (enExample)
AR (1) AR010875A1 (enExample)
AU (1) AU5609998A (enExample)
CA (1) CA2277220A1 (enExample)
WO (1) WO1998030208A1 (enExample)
ZA (1) ZA9880B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
GB9901688D0 (en) * 1999-01-26 1999-03-17 Unilever Plc Detergent compositions
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US6960357B2 (en) * 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US7052706B2 (en) * 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030152622A1 (en) * 2001-10-25 2003-08-14 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral diuretic
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
MXPA04006163A (es) * 2001-12-20 2004-11-01 Pharmacia Corp Formas de dosis de liberacion sostenida del orden-cero y metodo de fabricacion de las mismas.
PT1485078E (pt) * 2002-03-15 2013-01-14 Cypress Bioscience Inc Milnacipran para o tratamento do síndrome do intestino irritável
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
WO2004052367A1 (en) * 2002-12-06 2004-06-24 Ucb Farchim, S.A. Tablet comprising efletirizine and pseudoephedrine
AU2004207578B2 (en) * 2003-01-28 2007-06-28 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
MXPA05009469A (es) * 2003-03-04 2005-12-12 Nostrum Pharmaceuticals Inc Formulacion de liberacion controlada que contiene un material hidrofobico como agente de liberacion prolongada.
CN1819821B (zh) * 2003-08-08 2010-10-13 拜奥维尔实验室国际股份有限公司 盐酸安非他酮的改良释放片剂
ES2390879T3 (es) * 2003-12-31 2012-11-19 Actavis Group Ptc Ehf. Formulaciones de atomoxetina
WO2006010640A1 (en) * 2004-07-29 2006-02-02 Sanofi-Aventis Pharmaceutical multilayer tablet for controlled release of active ingredients with highly ph-dependent solubility
ZA200802602B (en) * 2005-08-24 2009-10-28 Rubicon Res Pvt Ltd Controlled release formulation
US8691272B2 (en) 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
JP4953673B2 (ja) * 2006-03-22 2012-06-13 リンテック株式会社 経口投与剤
US20080107725A1 (en) * 2006-10-13 2008-05-08 Albano Antonio A Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
KR100885029B1 (ko) 2007-02-07 2009-02-23 지엘팜텍 주식회사 경구투여용 서방성 삼중정제
CA2715584A1 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd. Oral controlled release tablet
US20100260842A1 (en) * 2009-04-06 2010-10-14 Rashmi Nair Pseudoephedrine pharmaceutical formulations
MX2012001393A (es) * 2009-08-05 2012-08-03 Lupin Ltd Composiciones farmacéuticas de liberación controlada de milnacipran.
US9572909B2 (en) * 2009-09-14 2017-02-21 Virginia Commonwealth University Electrospun nerve guides for nerve regeneration designed to modulate nerve architecture
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US10485770B2 (en) 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
GB2479213B (en) 2010-04-01 2013-07-10 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
KR102600541B1 (ko) 2016-01-20 2023-11-08 테라비다, 인코포레이티드 다한증을 치료하기 위한 방법 및 조성물
EP3788884A1 (de) * 2019-09-05 2021-03-10 Delica AG Kompostierbare kapsel sowie deren herstellung und verwendung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109293C (enExample) * 1955-12-22
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US5114719A (en) * 1987-04-29 1992-05-19 Sabel Bernhard A Extended drug delivery of small, water-soluble molecules
DE3871343D1 (de) * 1987-11-25 1992-06-25 American Cyanamid Co System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridin-calciumantagonisten.
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
EP0664118B1 (en) * 1991-10-04 1999-08-25 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release tablet
JPH0791500B2 (ja) * 1991-10-25 1995-10-04 太田インキ製造株式会社 印刷インキ組成物
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
CA2136810A1 (en) * 1994-06-30 1995-12-31 Franklin M. C. Chen Absorbent structure including an adhesive

Also Published As

Publication number Publication date
AR010875A1 (es) 2000-07-12
WO1998030208A1 (en) 1998-07-16
CA2277220A1 (en) 1998-07-16
JP2001508440A (ja) 2001-06-26
EP0951279A1 (en) 1999-10-27
ZA9880B (en) 1998-07-08
US6033685A (en) 2000-03-07
AU5609998A (en) 1998-08-03

Similar Documents

Publication Publication Date Title
US6033685A (en) Tablet for the controlled release of active agents
EP0598309B1 (en) Multilayer matrix systems for the controlled release of active principles
AU693313B2 (en) A controlled release drug suspension delivery device
KR100618234B1 (ko) 다공성 입자를 포함하는 제형
EP0516141B1 (en) Pharmaceutical controlled-release composition with bioadhesive properties
JP3797388B2 (ja) アルフゾシン塩酸塩の放出制御錠剤
AU719170B2 (en) Pharmaceutical compressed tablet characterized by a high increase in volume by contact with biological fluids
EP0542364B1 (en) Controlled release device
CA2085871C (en) A controlled release drug dispersion delivery device
US7338667B2 (en) Pharmaceutical formulation
US20030003151A1 (en) Chemical delivery device
JPH07119171B2 (ja) ヒドロゲルを用いた徐放製剤
KR20030024844A (ko) 히드로겔 구동되는 약물 제형
MXPA97004672A (en) Device supplier of suspension of farmaco, control deliberation
KR101650213B1 (ko) 생체접착성 컴팩트 매트릭스의 제조방법
EP1450783A1 (en) New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
JP4563642B2 (ja) 医薬製剤
CA2206211C (en) A controlled release drug suspension delivery device
US20040265381A1 (en) Anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
HK1062632A1 (en) Pharmaceutical formulation with extended release
HK1062632B (en) Pharmaceutical formulation with extended release

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040909

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040909

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080425

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080609

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080805

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20081007

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090203

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20090219

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20090827

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110520

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110531

RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20111018

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120321

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120328

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120723

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121016

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20121101

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20121204

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121221

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees